1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Biopharmaceutical Analysis & Statistics, June 2016 (p7)

Biopharmaceutical Analysis & Statistics, June 2016 (p7)

24/7 Customer Support

Talk to Nicolas

+1 718 473 0872

Publishers

181-210 of about 700 reports

Purchase Reports From Reputable Market Research Publishers

Accentia Biopharmaceuticals, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Accentia Biopharmaceuticals, Inc.: Financial Highlights

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

SummaryMarketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : United States
CTI BioPharma Corp. (formerly Cell Therapeutics, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

CTI BioPharma Corp. (formerly Cell Therapeutics, Inc.): Financial Highlights

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

SummaryMarketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Industries : Therapy, Biopharmaceutical, Pharmaceutical, Biotechnology
  • Countries : United States
EPIRUS Biopharmaceuticals, Inc. (formerly Zalicus, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

EPIRUS Biopharmaceuticals, Inc. (formerly Zalicus, Inc.): Financial Highlights

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

SummaryMarketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Industries : Biopharmaceutical, Pharmaceutical, Biotechnology
  • Countries : United States
DSM Pharmaceutical Products – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

DSM Pharmaceutical Products: Financial Highlights

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

SummaryMarketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Industries : Pharmaceutical
  • Countries : United States
Soligenix, Inc. (formerly DOR BioPharma, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Soligenix, Inc. (formerly DOR BioPharma, Inc.): Financial Highlights

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

SummaryMarketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Industries : Biopharmaceutical
  • Countries : United States
Abeona Therapeutics, Inc. (formerly PlasmaTech Biopharmaceuticals, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Abeona Therapeutics, Inc. (formerly PlasmaTech Biopharmaceuticals, Inc.): Financial Highlights

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

SummaryMarketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Industries : Pharmaceutical, Therapy
  • Countries : United States
Navidea Biopharmaceuticals, Inc. (formerly Neoprobe Corporation) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Navidea Biopharmaceuticals, Inc. (formerly Neoprobe Corporation): Financial Highlights

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

SummaryMarketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : United States
Emergent Biosolutions, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Emergent Biosolutions, Inc.: Financial Highlights

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

SummaryMarketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Industries : Pharmaceutical
  • Countries : United States
RedHill Biopharma, Ltd. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

RedHill Biopharma, Ltd.: Financial Highlights

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

SummaryMarketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Industries : Biopharmaceutical
  • Countries : United States
PDL BioPharma, Inc. (formerly Protein Design Labs, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

PDL BioPharma, Inc. (formerly Protein Design Labs, Inc.): Financial Highlights

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

SummaryMarketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Industries : Pharmaceutical, Biopharmaceutical
  • Countries : United States
Alexion Pharmaceuticals, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Alexion Pharmaceuticals, Inc.: Financial Highlights

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

SummaryMarketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Industries : Pharmaceutical, Biopharmaceutical, Therapy
  • Countries : United States
Kythera Biopharmaceuticals, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Kythera Biopharmaceuticals, Inc.: Financial Highlights

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

SummaryMarketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Industries : Biopharmaceutical
  • Countries : United States
Intas Pharmaceuticals, Ltd. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Intas Pharmaceuticals, Ltd.: Financial Highlights

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

SummaryMarketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Industries : Pharmaceutical
  • Countries : United States
Biota Pharmaceuticals, Inc. (formerly Nabi Biopharmaceuticals, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Biota Pharmaceuticals, Inc. (formerly Nabi Biopharmaceuticals, Inc.): Financial Highlights

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

SummaryMarketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Industries : Pharmaceutical
  • Countries : United States, United Kingdom
Array BioPharma, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Array BioPharma, Inc.: Financial Highlights

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

SummaryMarketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : United States
Proteases Market by Source , Formulation , Product , Application , & by Region - Global Forecast to 2021

Proteases Market: Global Forecast until 2021

  • $ 5650
  • Industry report
  • June 2016
  • by MarketsandMarkets

This report analyzes the proteases market, in terms of source, application, methods of production, formulation, product, and region. The proteases market has grown rapidly in the last few years and is ...

  • Industries : Biopharmaceutical
  • Countries : World, Asia, Europe, North America
Global Endocrinology Drugs Market 2016-2020

Endocrinology Drugs Sector: Worldwide Forecast until 2020

  • $ 2500
  • Industry report
  • April 2016
  • by Infiniti Research Limited

About Endocrinology DrugsEndocrinology deals with the study of the endocrine system, including the biochemical and physiological functions of the hormones, cells, and tissues of the endocrine glands. Endocrine ...

  • Industries : Therapy, Pharmaceutical, Pathology, Chronic Disease
  • Countries : World
Cell Lysis/Cell Fractionation Market by Product, Instruments, Type of Cell, End User - Global Forecasts to 2021

Cell Lysis/Cell Fractionation Market: Global Forecasts until 2021

  • $ 5650
  • Industry report
  • April 2016
  • by MarketsandMarkets

The cell lysis market is expected to reach USD 3.84 billion by 2021 from USD 2.35 billion in 2016, at a CAGR of 10.3%. The global cell lysis market is segmented based on product, type of cell, end-users, ...

  • Industries : Biotechnology, Biopharmaceutical
  • Countries : North America, World
Novozymes Biopharma UK, Ltd. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Novozymes Biopharma UK, Ltd.: Financial Highlights

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis:Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biopharmaceutical
  • Countries : United Kingdom
Oncolys Biopharma, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Oncolys Biopharma, Inc.: Financial Highlights

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis:Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
  • Countries : United States
Itero Biopharmaceuticals, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Itero Biopharmaceuticals, Inc.: Financial Highlights

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis:Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Countries : United Kingdom
Hemispherx Biopharma, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Hemispherx Biopharma, Inc.: Financial Highlights

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis:Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biopharmaceutical
  • Countries : United States, United Kingdom
Pronova BioPharma ASA – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Pronova BioPharma ASA: Financial Highlights

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis:Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
  • Countries : United States, United Kingdom
Keryx Biopharmaceuticals, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Keryx Biopharmaceuticals, Inc.: Financial Highlights

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis:Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : United States, United Kingdom, Japan
Viropro, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Viropro, Inc.: Financial Highlights

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis:Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Countries : United States, United Kingdom
Neuromed Pharmaceuticals, Ltd. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Neuromed Pharmaceuticals, Ltd.: Financial Highlights

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis:Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
  • Countries : Canada, United Kingdom
Scil Biomedicals GmbH – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Scil Biomedicals GmbH: Financial Highlights

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis:Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
  • Countries : Germany
Compass Biotechnologies, Inc. (formerly Cyplasin Biomedical, Ltd.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Compass Biotechnologies, Inc. (formerly Cyplasin Biomedical, Ltd.): Financial Highlights

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis:Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
  • Countries : United States, United Kingdom, Canada
Synageva BioPharma Corp. (formerly AviGenics, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Synageva BioPharma Corp. (formerly AviGenics, Inc.): Financial Highlights

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis:Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biopharmaceutical
  • Countries : United States
Aldagen, Inc. (formerly Stemco Biomedical, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Aldagen, Inc. (formerly Stemco Biomedical, Inc.): Financial Highlights

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis:Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Countries : United States

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.